Identification of genetic markers in individuals predisposed to tumor development after occupational or environmental exposure to potential carcinogens requires an understanding of how specific genes determine susceptibility to chemical-induced carcinogenesis. Knowledge of the proportion of susceptible individuals in the population and the relative cancer susceptibility of normal and predisposed groups will make it possible to estimate human risk from carcinogen exposure. In addition, tumor development after carcinogen exposure often exhibits tissue specificity. Studies on the genetic basis of carcinogen susceptibility must therefore take into account both the specific tissue and cell type affected by the carcinogen and genetic restrictions that may exist in various cell types that effect cancer susceptibility. Hydroquinone (HQ) is a carcinogen that exhibits both species and tissue selectivity, and in prior grant years we have established that species differences exist in susceptibility to the acute effects of the nephrotoxic metabolites of HQ. We will extend these findings to identify the genetic/molecular basis for these differences.
In Specific Aim 1 we hypothesize that genetically determined differences in bioactivation, and/or presence of susceptibility factors, including the ability to repair tissue damage, contribute to species susceptibility to hydroquinone induced neoplasia. The molecular control of each of these variables will be determined in species susceptible or resistant to both the acute and chronic effects of HQ, and its nephrotoxic metabolite, 2,3,5-(trisglutathion-S-yl)HQ. In human renal cell carcinoma (RCC) loss of heterozygosity of chromosome 3 occurs frequently, and inheritance of an alteration at this putative tumor suppressor predisposes to the development of RCC. In Eker rats, a single gene mutation predisposes to multiple bilateral RCCs with an autosomal dominant pattern of inheritance, and animals carrying the Eker mutation serve as a model for hereditary RCC. The second Specific Aim in this revised competing renewal application will therefore focus on the interaction between genetic predispositions and chemical exposure on susceptibility to renal cancer, in the Eker rat model. The overall goals of this aim are to characterize the Eker animal model in which the effects of environmental influences (chemical exposure) on a genetic predisposition to cancer are determined.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM039338-12
Application #
6490020
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Okita, Richard T
Project Start
1988-02-01
Project End
2003-12-31
Budget Start
2002-01-01
Budget End
2002-12-31
Support Year
12
Fiscal Year
2002
Total Cost
$239,142
Indirect Cost
Name
University of Texas Austin
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
Austin
State
TX
Country
United States
Zip Code
78712
Cohen, Jennifer D; Labenski, Matthew; Mastrandrea, Nicholas J et al. (2016) Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma. Mol Carcinog 55:1243-50
Cohen, Jennifer D; Tham, Kimberly Y; Mastrandrea, Nicholas J et al. (2011) cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma. Toxicol Sci 122:361-71
Cohen, Jennifer D; Gard, Jaime M C; Nagle, Raymond B et al. (2011) ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma. Toxicol Sci 124:75-87